More than 1,000 actions have been filed against C.R. Bard, Inc. about its defective Meridian IVC Filter in litigation consolidated in Arizona federal court before US District Judge David G. Campbell. The C.R. Bard IVC Filter Litigation MDL 2641 was created on August 17, 2015.
The latest case is filed by Aleasia J. P., a woman from Virginia who was implanted with the C.R. Bard Meridian® Vena Cava Filter on October 12, 2012 at a hospital in Virginia. The action was filed on November 8, 2016 in the U.S. District Court for the District of Arizona, Case No. 2:16-cv-03871.
Knew device was defective
Bard no longer manufactures or sells the Meridian in the United States. Product liability and injury lawsuits filed against Bard, Cordis and other retrievable IVC filter makers allege that these companies knew or should have known that the devices were defective because:
- The defendants failed to conduct proper testing, including human clinical testing, to determine how the devices actually functioned in the body.
- Published medical studies have found many complications including fracture, device migration, perforation of the vena cava wall, organ penetration, and increased risk for venous thrombosis.
- The defendants misrepresented the risks with retrievable ICVs and failed to issue appropriate safety warnings to patients and physicians.
Meridian is a temporary filter that consists of 12 needle-like legs arranged in a cone-shape around a central hook. It is implanted in a major blood vessel called the inferior vena cava (IVC) to catch blood clots and prevent pulmonary embolisms
Meridian was approved by the FDA in 2011 with a 510(k) application, which means it did not go through clinical trials because it was “equivalent” to several other IVC filters made by C.R. Bard. Unfortunately, these other filters have been linked to serious risks.
Meridian is similar to the Recovery, which was introduced in 2003 and withdrawn in the market in 2005. In 2012, a study of 363 patients estimated that 40% would fracture within 5.5 years. See Class Action Charges Company Lied to Cover Up Defective Bard IVC Filter
Meridian is also very similar to the G2, which C.R. Bard introduced in 2005 to replace the Recovery. In June 2014, a study of 829 patients implanted with the G2 estimated that 38% would fracture within 5 years, with the risk increasing over time.